Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
9,144
archived clinical trials in
Ocular

PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial
PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial
Status: Enrolling
Updated:  12/31/1969
Unniversity of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial
PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial
Status: Enrolling
Updated: 12/31/1969
Unniversity of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
A Clinical Trial of The VisAbility Micro Insert System for Presbyopic Patients
A Prospective, Multicenter Clinical Trial Of The VisAbility Micro Insert System For Improvement Of Near Visual Acuity In Presbyopic Patients
Status: Enrolling
Updated:  12/31/1969
Coastal Vision
mi
from
Orange, CA
A Clinical Trial of The VisAbility Micro Insert System for Presbyopic Patients
A Prospective, Multicenter Clinical Trial Of The VisAbility Micro Insert System For Improvement Of Near Visual Acuity In Presbyopic Patients
Status: Enrolling
Updated: 12/31/1969
Coastal Vision
mi
from
Orange, CA
Click here to add this to my saved trials
A Clinical Trial of The VisAbility Micro Insert System for Presbyopic Patients
A Prospective, Multicenter Clinical Trial Of The VisAbility Micro Insert System For Improvement Of Near Visual Acuity In Presbyopic Patients
Status: Enrolling
Updated:  12/31/1969
Gordon -Weiss Vision Institute
mi
from
San Diego, CA
A Clinical Trial of The VisAbility Micro Insert System for Presbyopic Patients
A Prospective, Multicenter Clinical Trial Of The VisAbility Micro Insert System For Improvement Of Near Visual Acuity In Presbyopic Patients
Status: Enrolling
Updated: 12/31/1969
Gordon -Weiss Vision Institute
mi
from
San Diego, CA
Click here to add this to my saved trials
A Clinical Trial of The VisAbility Micro Insert System for Presbyopic Patients
A Prospective, Multicenter Clinical Trial Of The VisAbility Micro Insert System For Improvement Of Near Visual Acuity In Presbyopic Patients
Status: Enrolling
Updated:  12/31/1969
Aloha Laser Vision
mi
from
Honolulu, HI
A Clinical Trial of The VisAbility Micro Insert System for Presbyopic Patients
A Prospective, Multicenter Clinical Trial Of The VisAbility Micro Insert System For Improvement Of Near Visual Acuity In Presbyopic Patients
Status: Enrolling
Updated: 12/31/1969
Aloha Laser Vision
mi
from
Honolulu, HI
Click here to add this to my saved trials
A Clinical Trial of The VisAbility Micro Insert System for Presbyopic Patients
A Prospective, Multicenter Clinical Trial Of The VisAbility Micro Insert System For Improvement Of Near Visual Acuity In Presbyopic Patients
Status: Enrolling
Updated:  12/31/1969
Midwest Center for Sight
mi
from
Des Plaines, IL
A Clinical Trial of The VisAbility Micro Insert System for Presbyopic Patients
A Prospective, Multicenter Clinical Trial Of The VisAbility Micro Insert System For Improvement Of Near Visual Acuity In Presbyopic Patients
Status: Enrolling
Updated: 12/31/1969
Midwest Center for Sight
mi
from
Des Plaines, IL
Click here to add this to my saved trials
A Clinical Trial of The VisAbility Micro Insert System for Presbyopic Patients
A Prospective, Multicenter Clinical Trial Of The VisAbility Micro Insert System For Improvement Of Near Visual Acuity In Presbyopic Patients
Status: Enrolling
Updated:  12/31/1969
Eye Surgeons of Indiana
mi
from
Indianapolis, IN
A Clinical Trial of The VisAbility Micro Insert System for Presbyopic Patients
A Prospective, Multicenter Clinical Trial Of The VisAbility Micro Insert System For Improvement Of Near Visual Acuity In Presbyopic Patients
Status: Enrolling
Updated: 12/31/1969
Eye Surgeons of Indiana
mi
from
Indianapolis, IN
Click here to add this to my saved trials
A Clinical Trial of The VisAbility Micro Insert System for Presbyopic Patients
A Prospective, Multicenter Clinical Trial Of The VisAbility Micro Insert System For Improvement Of Near Visual Acuity In Presbyopic Patients
Status: Enrolling
Updated:  12/31/1969
The Eye Care Institute
mi
from
Louisville, KY
A Clinical Trial of The VisAbility Micro Insert System for Presbyopic Patients
A Prospective, Multicenter Clinical Trial Of The VisAbility Micro Insert System For Improvement Of Near Visual Acuity In Presbyopic Patients
Status: Enrolling
Updated: 12/31/1969
The Eye Care Institute
mi
from
Louisville, KY
Click here to add this to my saved trials
A Clinical Trial of The VisAbility Micro Insert System for Presbyopic Patients
A Prospective, Multicenter Clinical Trial Of The VisAbility Micro Insert System For Improvement Of Near Visual Acuity In Presbyopic Patients
Status: Enrolling
Updated:  12/31/1969
Chu Vision Institute
mi
from
Bloomington, MN
A Clinical Trial of The VisAbility Micro Insert System for Presbyopic Patients
A Prospective, Multicenter Clinical Trial Of The VisAbility Micro Insert System For Improvement Of Near Visual Acuity In Presbyopic Patients
Status: Enrolling
Updated: 12/31/1969
Chu Vision Institute
mi
from
Bloomington, MN
Click here to add this to my saved trials
A Clinical Trial of The VisAbility Micro Insert System for Presbyopic Patients
A Prospective, Multicenter Clinical Trial Of The VisAbility Micro Insert System For Improvement Of Near Visual Acuity In Presbyopic Patients
Status: Enrolling
Updated:  12/31/1969
South Shore Eye Care LLP
mi
from
Wantagh, NY
A Clinical Trial of The VisAbility Micro Insert System for Presbyopic Patients
A Prospective, Multicenter Clinical Trial Of The VisAbility Micro Insert System For Improvement Of Near Visual Acuity In Presbyopic Patients
Status: Enrolling
Updated: 12/31/1969
South Shore Eye Care LLP
mi
from
Wantagh, NY
Click here to add this to my saved trials
A Clinical Trial of The VisAbility Micro Insert System for Presbyopic Patients
A Prospective, Multicenter Clinical Trial Of The VisAbility Micro Insert System For Improvement Of Near Visual Acuity In Presbyopic Patients
Status: Enrolling
Updated:  12/31/1969
Physicians Protocol
mi
from
Greensboro, NC
A Clinical Trial of The VisAbility Micro Insert System for Presbyopic Patients
A Prospective, Multicenter Clinical Trial Of The VisAbility Micro Insert System For Improvement Of Near Visual Acuity In Presbyopic Patients
Status: Enrolling
Updated: 12/31/1969
Physicians Protocol
mi
from
Greensboro, NC
Click here to add this to my saved trials
A Clinical Trial of The VisAbility Micro Insert System for Presbyopic Patients
A Prospective, Multicenter Clinical Trial Of The VisAbility Micro Insert System For Improvement Of Near Visual Acuity In Presbyopic Patients
Status: Enrolling
Updated:  12/31/1969
Comprehensive EyeCare of Central Ohio
mi
from
Westerville, OH
A Clinical Trial of The VisAbility Micro Insert System for Presbyopic Patients
A Prospective, Multicenter Clinical Trial Of The VisAbility Micro Insert System For Improvement Of Near Visual Acuity In Presbyopic Patients
Status: Enrolling
Updated: 12/31/1969
Comprehensive EyeCare of Central Ohio
mi
from
Westerville, OH
Click here to add this to my saved trials
A Clinical Trial of The VisAbility Micro Insert System for Presbyopic Patients
A Prospective, Multicenter Clinical Trial Of The VisAbility Micro Insert System For Improvement Of Near Visual Acuity In Presbyopic Patients
Status: Enrolling
Updated:  12/31/1969
Bucci Laser Vision
mi
from
Wilkes-Barre, PA
A Clinical Trial of The VisAbility Micro Insert System for Presbyopic Patients
A Prospective, Multicenter Clinical Trial Of The VisAbility Micro Insert System For Improvement Of Near Visual Acuity In Presbyopic Patients
Status: Enrolling
Updated: 12/31/1969
Bucci Laser Vision
mi
from
Wilkes-Barre, PA
Click here to add this to my saved trials
A Clinical Trial of The VisAbility Micro Insert System for Presbyopic Patients
A Prospective, Multicenter Clinical Trial Of The VisAbility Micro Insert System For Improvement Of Near Visual Acuity In Presbyopic Patients
Status: Enrolling
Updated:  12/31/1969
Key-Whitman Eye Center
mi
from
Dallas, TX
A Clinical Trial of The VisAbility Micro Insert System for Presbyopic Patients
A Prospective, Multicenter Clinical Trial Of The VisAbility Micro Insert System For Improvement Of Near Visual Acuity In Presbyopic Patients
Status: Enrolling
Updated: 12/31/1969
Key-Whitman Eye Center
mi
from
Dallas, TX
Click here to add this to my saved trials
A Clinical Trial of The VisAbility Micro Insert System for Presbyopic Patients
A Prospective, Multicenter Clinical Trial Of The VisAbility Micro Insert System For Improvement Of Near Visual Acuity In Presbyopic Patients
Status: Enrolling
Updated:  12/31/1969
Braverman-Terry-Oei Eye Associates
mi
from
San Antonio, TX
A Clinical Trial of The VisAbility Micro Insert System for Presbyopic Patients
A Prospective, Multicenter Clinical Trial Of The VisAbility Micro Insert System For Improvement Of Near Visual Acuity In Presbyopic Patients
Status: Enrolling
Updated: 12/31/1969
Braverman-Terry-Oei Eye Associates
mi
from
San Antonio, TX
Click here to add this to my saved trials
RAINBOW Study: RAnibizumab Compared With Laser Therapy for the Treatment of INfants BOrn Prematurely With Retinopathy of Prematurity
RAINBOW Study: a Randomized, Controlled Study Evaluating the Efficacy and Safety of RAnibizumab Compared With Laser Therapy for the Treatment of INfants BOrn Prematurely With Retinopathy of Prematurity
Status: Enrolling
Updated:  12/31/1969
Novartis Investigative Site
mi
from
Graz,
RAINBOW Study: RAnibizumab Compared With Laser Therapy for the Treatment of INfants BOrn Prematurely With Retinopathy of Prematurity
RAINBOW Study: a Randomized, Controlled Study Evaluating the Efficacy and Safety of RAnibizumab Compared With Laser Therapy for the Treatment of INfants BOrn Prematurely With Retinopathy of Prematurity
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Graz,
Click here to add this to my saved trials
RAINBOW Study: RAnibizumab Compared With Laser Therapy for the Treatment of INfants BOrn Prematurely With Retinopathy of Prematurity
RAINBOW Study: a Randomized, Controlled Study Evaluating the Efficacy and Safety of RAnibizumab Compared With Laser Therapy for the Treatment of INfants BOrn Prematurely With Retinopathy of Prematurity
Status: Enrolling
Updated:  12/31/1969
Novartis Investigative Site
mi
from
Sacramento, CA
RAINBOW Study: RAnibizumab Compared With Laser Therapy for the Treatment of INfants BOrn Prematurely With Retinopathy of Prematurity
RAINBOW Study: a Randomized, Controlled Study Evaluating the Efficacy and Safety of RAnibizumab Compared With Laser Therapy for the Treatment of INfants BOrn Prematurely With Retinopathy of Prematurity
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Sacramento, CA
Click here to add this to my saved trials
RAINBOW Study: RAnibizumab Compared With Laser Therapy for the Treatment of INfants BOrn Prematurely With Retinopathy of Prematurity
RAINBOW Study: a Randomized, Controlled Study Evaluating the Efficacy and Safety of RAnibizumab Compared With Laser Therapy for the Treatment of INfants BOrn Prematurely With Retinopathy of Prematurity
Status: Enrolling
Updated:  12/31/1969
Novartis Investigative Site
mi
from
Salt Lake City, UT
RAINBOW Study: RAnibizumab Compared With Laser Therapy for the Treatment of INfants BOrn Prematurely With Retinopathy of Prematurity
RAINBOW Study: a Randomized, Controlled Study Evaluating the Efficacy and Safety of RAnibizumab Compared With Laser Therapy for the Treatment of INfants BOrn Prematurely With Retinopathy of Prematurity
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
RAINBOW Study: RAnibizumab Compared With Laser Therapy for the Treatment of INfants BOrn Prematurely With Retinopathy of Prematurity
RAINBOW Study: a Randomized, Controlled Study Evaluating the Efficacy and Safety of RAnibizumab Compared With Laser Therapy for the Treatment of INfants BOrn Prematurely With Retinopathy of Prematurity
Status: Enrolling
Updated:  12/31/1969
Novartis Investigative Site
mi
from
Loma Linda, CA
RAINBOW Study: RAnibizumab Compared With Laser Therapy for the Treatment of INfants BOrn Prematurely With Retinopathy of Prematurity
RAINBOW Study: a Randomized, Controlled Study Evaluating the Efficacy and Safety of RAnibizumab Compared With Laser Therapy for the Treatment of INfants BOrn Prematurely With Retinopathy of Prematurity
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Loma Linda, CA
Click here to add this to my saved trials
RAINBOW Study: RAnibizumab Compared With Laser Therapy for the Treatment of INfants BOrn Prematurely With Retinopathy of Prematurity
RAINBOW Study: a Randomized, Controlled Study Evaluating the Efficacy and Safety of RAnibizumab Compared With Laser Therapy for the Treatment of INfants BOrn Prematurely With Retinopathy of Prematurity
Status: Enrolling
Updated:  12/31/1969
Novartis Investigator Site
mi
from
Chicago, IL
RAINBOW Study: RAnibizumab Compared With Laser Therapy for the Treatment of INfants BOrn Prematurely With Retinopathy of Prematurity
RAINBOW Study: a Randomized, Controlled Study Evaluating the Efficacy and Safety of RAnibizumab Compared With Laser Therapy for the Treatment of INfants BOrn Prematurely With Retinopathy of Prematurity
Status: Enrolling
Updated: 12/31/1969
Novartis Investigator Site
mi
from
Chicago, IL
Click here to add this to my saved trials
RAINBOW Study: RAnibizumab Compared With Laser Therapy for the Treatment of INfants BOrn Prematurely With Retinopathy of Prematurity
RAINBOW Study: a Randomized, Controlled Study Evaluating the Efficacy and Safety of RAnibizumab Compared With Laser Therapy for the Treatment of INfants BOrn Prematurely With Retinopathy of Prematurity
Status: Enrolling
Updated:  12/31/1969
Novartis Investigative Site
mi
from
Louisville, KY
RAINBOW Study: RAnibizumab Compared With Laser Therapy for the Treatment of INfants BOrn Prematurely With Retinopathy of Prematurity
RAINBOW Study: a Randomized, Controlled Study Evaluating the Efficacy and Safety of RAnibizumab Compared With Laser Therapy for the Treatment of INfants BOrn Prematurely With Retinopathy of Prematurity
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Louisville, KY
Click here to add this to my saved trials
RAINBOW Study: RAnibizumab Compared With Laser Therapy for the Treatment of INfants BOrn Prematurely With Retinopathy of Prematurity
RAINBOW Study: a Randomized, Controlled Study Evaluating the Efficacy and Safety of RAnibizumab Compared With Laser Therapy for the Treatment of INfants BOrn Prematurely With Retinopathy of Prematurity
Status: Enrolling
Updated:  12/31/1969
Novartis Investigative site
mi
from
Boston, MA
RAINBOW Study: RAnibizumab Compared With Laser Therapy for the Treatment of INfants BOrn Prematurely With Retinopathy of Prematurity
RAINBOW Study: a Randomized, Controlled Study Evaluating the Efficacy and Safety of RAnibizumab Compared With Laser Therapy for the Treatment of INfants BOrn Prematurely With Retinopathy of Prematurity
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative site
mi
from
Boston, MA
Click here to add this to my saved trials
RAINBOW Study: RAnibizumab Compared With Laser Therapy for the Treatment of INfants BOrn Prematurely With Retinopathy of Prematurity
RAINBOW Study: a Randomized, Controlled Study Evaluating the Efficacy and Safety of RAnibizumab Compared With Laser Therapy for the Treatment of INfants BOrn Prematurely With Retinopathy of Prematurity
Status: Enrolling
Updated:  12/31/1969
Novartis Investigative Site
mi
from
Ann Arbor, MI
RAINBOW Study: RAnibizumab Compared With Laser Therapy for the Treatment of INfants BOrn Prematurely With Retinopathy of Prematurity
RAINBOW Study: a Randomized, Controlled Study Evaluating the Efficacy and Safety of RAnibizumab Compared With Laser Therapy for the Treatment of INfants BOrn Prematurely With Retinopathy of Prematurity
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
RAINBOW Study: RAnibizumab Compared With Laser Therapy for the Treatment of INfants BOrn Prematurely With Retinopathy of Prematurity
RAINBOW Study: a Randomized, Controlled Study Evaluating the Efficacy and Safety of RAnibizumab Compared With Laser Therapy for the Treatment of INfants BOrn Prematurely With Retinopathy of Prematurity
Status: Enrolling
Updated:  12/31/1969
Novartis Investigative Site
mi
from
Rochester, NY
RAINBOW Study: RAnibizumab Compared With Laser Therapy for the Treatment of INfants BOrn Prematurely With Retinopathy of Prematurity
RAINBOW Study: a Randomized, Controlled Study Evaluating the Efficacy and Safety of RAnibizumab Compared With Laser Therapy for the Treatment of INfants BOrn Prematurely With Retinopathy of Prematurity
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Rochester, NY
Click here to add this to my saved trials
RAINBOW Study: RAnibizumab Compared With Laser Therapy for the Treatment of INfants BOrn Prematurely With Retinopathy of Prematurity
RAINBOW Study: a Randomized, Controlled Study Evaluating the Efficacy and Safety of RAnibizumab Compared With Laser Therapy for the Treatment of INfants BOrn Prematurely With Retinopathy of Prematurity
Status: Enrolling
Updated:  12/31/1969
Novartis Investigative Site
mi
from
Morgantown, WV
RAINBOW Study: RAnibizumab Compared With Laser Therapy for the Treatment of INfants BOrn Prematurely With Retinopathy of Prematurity
RAINBOW Study: a Randomized, Controlled Study Evaluating the Efficacy and Safety of RAnibizumab Compared With Laser Therapy for the Treatment of INfants BOrn Prematurely With Retinopathy of Prematurity
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Morgantown, WV
Click here to add this to my saved trials
RAINBOW Study: RAnibizumab Compared With Laser Therapy for the Treatment of INfants BOrn Prematurely With Retinopathy of Prematurity
RAINBOW Study: a Randomized, Controlled Study Evaluating the Efficacy and Safety of RAnibizumab Compared With Laser Therapy for the Treatment of INfants BOrn Prematurely With Retinopathy of Prematurity
Status: Enrolling
Updated:  12/31/1969
Novartis Investigative site
mi
from
Aurora, CO
RAINBOW Study: RAnibizumab Compared With Laser Therapy for the Treatment of INfants BOrn Prematurely With Retinopathy of Prematurity
RAINBOW Study: a Randomized, Controlled Study Evaluating the Efficacy and Safety of RAnibizumab Compared With Laser Therapy for the Treatment of INfants BOrn Prematurely With Retinopathy of Prematurity
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative site
mi
from
Aurora, CO
Click here to add this to my saved trials
RAINBOW Study: RAnibizumab Compared With Laser Therapy for the Treatment of INfants BOrn Prematurely With Retinopathy of Prematurity
RAINBOW Study: a Randomized, Controlled Study Evaluating the Efficacy and Safety of RAnibizumab Compared With Laser Therapy for the Treatment of INfants BOrn Prematurely With Retinopathy of Prematurity
Status: Enrolling
Updated:  12/31/1969
Novartis
mi
from
Baltimore, MD
RAINBOW Study: RAnibizumab Compared With Laser Therapy for the Treatment of INfants BOrn Prematurely With Retinopathy of Prematurity
RAINBOW Study: a Randomized, Controlled Study Evaluating the Efficacy and Safety of RAnibizumab Compared With Laser Therapy for the Treatment of INfants BOrn Prematurely With Retinopathy of Prematurity
Status: Enrolling
Updated: 12/31/1969
Novartis
mi
from
Baltimore, MD
Click here to add this to my saved trials
RAINBOW Study: RAnibizumab Compared With Laser Therapy for the Treatment of INfants BOrn Prematurely With Retinopathy of Prematurity
RAINBOW Study: a Randomized, Controlled Study Evaluating the Efficacy and Safety of RAnibizumab Compared With Laser Therapy for the Treatment of INfants BOrn Prematurely With Retinopathy of Prematurity
Status: Enrolling
Updated:  12/31/1969
Novartis Investigational Site
mi
from
Austin, TX
RAINBOW Study: RAnibizumab Compared With Laser Therapy for the Treatment of INfants BOrn Prematurely With Retinopathy of Prematurity
RAINBOW Study: a Randomized, Controlled Study Evaluating the Efficacy and Safety of RAnibizumab Compared With Laser Therapy for the Treatment of INfants BOrn Prematurely With Retinopathy of Prematurity
Status: Enrolling
Updated: 12/31/1969
Novartis Investigational Site
mi
from
Austin, TX
Click here to add this to my saved trials
Open Label Study to Assess the Efficacy and Safety of AKB-9778 in Subjects With Macular Edema Due to RVO
Phase 2a Open Label Study to Assess the Efficacy and Safety of Subcutaneous 15mg AKB-9778 Administered Twice Daily for 84 Days in Subjects With Retinal Vein Occlusion
Status: Enrolling
Updated:  12/31/1969
Wilmer Eye Institute
mi
from
Baltimore, MD
Open Label Study to Assess the Efficacy and Safety of AKB-9778 in Subjects With Macular Edema Due to RVO
Phase 2a Open Label Study to Assess the Efficacy and Safety of Subcutaneous 15mg AKB-9778 Administered Twice Daily for 84 Days in Subjects With Retinal Vein Occlusion
Status: Enrolling
Updated: 12/31/1969
Wilmer Eye Institute
mi
from
Baltimore, MD
Click here to add this to my saved trials
A 24 Month Phase 2a Open Label, Randomized Study of Avastin®, Lucentis®, or Eylea® (Anti-VEGF Therapy) Administered in Combination With Fovista® (Anti-PDGF BB Pegylated Aptamer)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Beverly Hills, CA
A 24 Month Phase 2a Open Label, Randomized Study of Avastin®, Lucentis®, or Eylea® (Anti-VEGF Therapy) Administered in Combination With Fovista® (Anti-PDGF BB Pegylated Aptamer)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Beverly Hills, CA
Click here to add this to my saved trials
A 24 Month Phase 2a Open Label, Randomized Study of Avastin®, Lucentis®, or Eylea® (Anti-VEGF Therapy) Administered in Combination With Fovista® (Anti-PDGF BB Pegylated Aptamer)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Sacramento, CA
A 24 Month Phase 2a Open Label, Randomized Study of Avastin®, Lucentis®, or Eylea® (Anti-VEGF Therapy) Administered in Combination With Fovista® (Anti-PDGF BB Pegylated Aptamer)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Sacramento, CA
Click here to add this to my saved trials
A 24 Month Phase 2a Open Label, Randomized Study of Avastin®, Lucentis®, or Eylea® (Anti-VEGF Therapy) Administered in Combination With Fovista® (Anti-PDGF BB Pegylated Aptamer)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Santa Ana, CA
A 24 Month Phase 2a Open Label, Randomized Study of Avastin®, Lucentis®, or Eylea® (Anti-VEGF Therapy) Administered in Combination With Fovista® (Anti-PDGF BB Pegylated Aptamer)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Santa Ana, CA
Click here to add this to my saved trials
A 24 Month Phase 2a Open Label, Randomized Study of Avastin®, Lucentis®, or Eylea® (Anti-VEGF Therapy) Administered in Combination With Fovista® (Anti-PDGF BB Pegylated Aptamer)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
New London, CT
A 24 Month Phase 2a Open Label, Randomized Study of Avastin®, Lucentis®, or Eylea® (Anti-VEGF Therapy) Administered in Combination With Fovista® (Anti-PDGF BB Pegylated Aptamer)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
New London, CT
Click here to add this to my saved trials
A 24 Month Phase 2a Open Label, Randomized Study of Avastin®, Lucentis®, or Eylea® (Anti-VEGF Therapy) Administered in Combination With Fovista® (Anti-PDGF BB Pegylated Aptamer)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Augusta, GA
A 24 Month Phase 2a Open Label, Randomized Study of Avastin®, Lucentis®, or Eylea® (Anti-VEGF Therapy) Administered in Combination With Fovista® (Anti-PDGF BB Pegylated Aptamer)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Augusta, GA
Click here to add this to my saved trials
A 24 Month Phase 2a Open Label, Randomized Study of Avastin®, Lucentis®, or Eylea® (Anti-VEGF Therapy) Administered in Combination With Fovista® (Anti-PDGF BB Pegylated Aptamer)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Oak Forest, IL
A 24 Month Phase 2a Open Label, Randomized Study of Avastin®, Lucentis®, or Eylea® (Anti-VEGF Therapy) Administered in Combination With Fovista® (Anti-PDGF BB Pegylated Aptamer)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Oak Forest, IL
Click here to add this to my saved trials
A 24 Month Phase 2a Open Label, Randomized Study of Avastin®, Lucentis®, or Eylea® (Anti-VEGF Therapy) Administered in Combination With Fovista® (Anti-PDGF BB Pegylated Aptamer)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Boston, MA
A 24 Month Phase 2a Open Label, Randomized Study of Avastin®, Lucentis®, or Eylea® (Anti-VEGF Therapy) Administered in Combination With Fovista® (Anti-PDGF BB Pegylated Aptamer)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
A 24 Month Phase 2a Open Label, Randomized Study of Avastin®, Lucentis®, or Eylea® (Anti-VEGF Therapy) Administered in Combination With Fovista® (Anti-PDGF BB Pegylated Aptamer)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Southfield, MI
A 24 Month Phase 2a Open Label, Randomized Study of Avastin®, Lucentis®, or Eylea® (Anti-VEGF Therapy) Administered in Combination With Fovista® (Anti-PDGF BB Pegylated Aptamer)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Southfield, MI
Click here to add this to my saved trials
A 24 Month Phase 2a Open Label, Randomized Study of Avastin®, Lucentis®, or Eylea® (Anti-VEGF Therapy) Administered in Combination With Fovista® (Anti-PDGF BB Pegylated Aptamer)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Minneapolis, MN
A 24 Month Phase 2a Open Label, Randomized Study of Avastin®, Lucentis®, or Eylea® (Anti-VEGF Therapy) Administered in Combination With Fovista® (Anti-PDGF BB Pegylated Aptamer)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Minneapolis, MN
Click here to add this to my saved trials
A 24 Month Phase 2a Open Label, Randomized Study of Avastin®, Lucentis®, or Eylea® (Anti-VEGF Therapy) Administered in Combination With Fovista® (Anti-PDGF BB Pegylated Aptamer)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Reno, NV
A 24 Month Phase 2a Open Label, Randomized Study of Avastin®, Lucentis®, or Eylea® (Anti-VEGF Therapy) Administered in Combination With Fovista® (Anti-PDGF BB Pegylated Aptamer)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Reno, NV
Click here to add this to my saved trials
A 24 Month Phase 2a Open Label, Randomized Study of Avastin®, Lucentis®, or Eylea® (Anti-VEGF Therapy) Administered in Combination With Fovista® (Anti-PDGF BB Pegylated Aptamer)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Rochester, NY
A 24 Month Phase 2a Open Label, Randomized Study of Avastin®, Lucentis®, or Eylea® (Anti-VEGF Therapy) Administered in Combination With Fovista® (Anti-PDGF BB Pegylated Aptamer)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Rochester, NY
Click here to add this to my saved trials
A 24 Month Phase 2a Open Label, Randomized Study of Avastin®, Lucentis®, or Eylea® (Anti-VEGF Therapy) Administered in Combination With Fovista® (Anti-PDGF BB Pegylated Aptamer)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Cleveland, OH
A 24 Month Phase 2a Open Label, Randomized Study of Avastin®, Lucentis®, or Eylea® (Anti-VEGF Therapy) Administered in Combination With Fovista® (Anti-PDGF BB Pegylated Aptamer)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Cleveland, OH
Click here to add this to my saved trials
A 24 Month Phase 2a Open Label, Randomized Study of Avastin®, Lucentis®, or Eylea® (Anti-VEGF Therapy) Administered in Combination With Fovista® (Anti-PDGF BB Pegylated Aptamer)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Ladson, SC
A 24 Month Phase 2a Open Label, Randomized Study of Avastin®, Lucentis®, or Eylea® (Anti-VEGF Therapy) Administered in Combination With Fovista® (Anti-PDGF BB Pegylated Aptamer)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Ladson, SC
Click here to add this to my saved trials
A 24 Month Phase 2a Open Label, Randomized Study of Avastin®, Lucentis®, or Eylea® (Anti-VEGF Therapy) Administered in Combination With Fovista® (Anti-PDGF BB Pegylated Aptamer)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Abilene, TX
A 24 Month Phase 2a Open Label, Randomized Study of Avastin®, Lucentis®, or Eylea® (Anti-VEGF Therapy) Administered in Combination With Fovista® (Anti-PDGF BB Pegylated Aptamer)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Abilene, TX
Click here to add this to my saved trials
A 24 Month Phase 2a Open Label, Randomized Study of Avastin®, Lucentis®, or Eylea® (Anti-VEGF Therapy) Administered in Combination With Fovista® (Anti-PDGF BB Pegylated Aptamer)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Amarillo, TX
A 24 Month Phase 2a Open Label, Randomized Study of Avastin®, Lucentis®, or Eylea® (Anti-VEGF Therapy) Administered in Combination With Fovista® (Anti-PDGF BB Pegylated Aptamer)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Amarillo, TX
Click here to add this to my saved trials
A 24 Month Phase 2a Open Label, Randomized Study of Avastin®, Lucentis®, or Eylea® (Anti-VEGF Therapy) Administered in Combination With Fovista® (Anti-PDGF BB Pegylated Aptamer)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
San Antonio, TX
A 24 Month Phase 2a Open Label, Randomized Study of Avastin®, Lucentis®, or Eylea® (Anti-VEGF Therapy) Administered in Combination With Fovista® (Anti-PDGF BB Pegylated Aptamer)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
A 24 Month Phase 2a Open Label, Randomized Study of Avastin®, Lucentis®, or Eylea® (Anti-VEGF Therapy) Administered in Combination With Fovista® (Anti-PDGF BB Pegylated Aptamer)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Silverdale, WA
A 24 Month Phase 2a Open Label, Randomized Study of Avastin®, Lucentis®, or Eylea® (Anti-VEGF Therapy) Administered in Combination With Fovista® (Anti-PDGF BB Pegylated Aptamer)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Silverdale, WA
Click here to add this to my saved trials
A 24 Month Phase 2a Open Label, Randomized Study of Avastin®, Lucentis®, or Eylea® (Anti-VEGF Therapy) Administered in Combination With Fovista® (Anti-PDGF BB Pegylated Aptamer)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Morgantown, WV
A 24 Month Phase 2a Open Label, Randomized Study of Avastin®, Lucentis®, or Eylea® (Anti-VEGF Therapy) Administered in Combination With Fovista® (Anti-PDGF BB Pegylated Aptamer)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Morgantown, WV
Click here to add this to my saved trials
A 24 Month Phase 2a Open Label, Randomized Study of Avastin®, Lucentis®, or Eylea® (Anti-VEGF Therapy) Administered in Combination With Fovista® (Anti-PDGF BB Pegylated Aptamer)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Huntingdon Valley, PA
A 24 Month Phase 2a Open Label, Randomized Study of Avastin®, Lucentis®, or Eylea® (Anti-VEGF Therapy) Administered in Combination With Fovista® (Anti-PDGF BB Pegylated Aptamer)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Huntingdon Valley, PA
Click here to add this to my saved trials
A 24 Month Phase 2a Open Label, Randomized Study of Avastin®, Lucentis®, or Eylea® (Anti-VEGF Therapy) Administered in Combination With Fovista® (Anti-PDGF BB Pegylated Aptamer)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Phoenix, AZ
A 24 Month Phase 2a Open Label, Randomized Study of Avastin®, Lucentis®, or Eylea® (Anti-VEGF Therapy) Administered in Combination With Fovista® (Anti-PDGF BB Pegylated Aptamer)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
A 24 Month Phase 2a Open Label, Randomized Study of Avastin®, Lucentis®, or Eylea® (Anti-VEGF Therapy) Administered in Combination With Fovista® (Anti-PDGF BB Pegylated Aptamer)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Fort Lauderdale, FL
A 24 Month Phase 2a Open Label, Randomized Study of Avastin®, Lucentis®, or Eylea® (Anti-VEGF Therapy) Administered in Combination With Fovista® (Anti-PDGF BB Pegylated Aptamer)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
A 24 Month Phase 2a Open Label, Randomized Study of Avastin®, Lucentis®, or Eylea® (Anti-VEGF Therapy) Administered in Combination With Fovista® (Anti-PDGF BB Pegylated Aptamer)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Fort Myers, FL
A 24 Month Phase 2a Open Label, Randomized Study of Avastin®, Lucentis®, or Eylea® (Anti-VEGF Therapy) Administered in Combination With Fovista® (Anti-PDGF BB Pegylated Aptamer)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Fort Myers, FL
Click here to add this to my saved trials